Modeling Human TBX5 Haploinsufficiency Predicts Regulatory Networks for Congenital Heart Disease
Irfan S. Kathiriya(Gladstone Institutes), Benoit G. Bruneau(Council of Science Editors), Laure D. Bernard(Gladstone Institutes), Kavitha S. Rao(Gladstone Institutes), Brynn N. Akerberg(C4 Therapeutics (United States)), Piyush Goyal(University of Bern), Lauren K. Wasson(Harvard University), Joshua M. Stuart(University of California, Santa Cruz), Reuben Thomas(Gladstone Institutes), Swetansu K. Hota(Gladstone Institutes), W. Patrick Devine(Cancer Research Institute), Henry Gong(University of California, Santa Cruz), Güneş Akgün(Gladstone Institutes), Bayardo I. Garay(Gladstone Institutes), Matthew L Speir(University of California, Santa Cruz), Giovanni Iacono(Centre for Genomic Regulation), Andrew P. Blair(Gladstone Institutes), Michael H. Lai(Gladstone Institutes), Holger Heyn(Scope Group (United States)), Maximilian Haeussler(University of California, Santa Cruz), William T. Pu(Brigham and Women's Hospital), Tatyana Sukonnik(Gladstone Institutes), Fei Gu(Boston Children's Hospital), Kai Li(University of Michigan), Kevin Hu(Gladstone Institutes), J G Seidman(Harvard University), Christine E. Seidman(Harvard University)
Cited by 130
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
|Nature Medicine|2007|2.2k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k